AINewsnow

VIDRAFT Launches Open Discovery Challenge Benchmarking LLMs on Drug Candidate Discovery

This story is from 2026-08-24. It is preserved in the archive; the latest stories are on the live feed.

Korean AI startup VIDRAFT launched the Open Discovery Challenge on Hugging Face, a public benchmark comparing frontier LLMs like OpenAI's GPT-4 and Claude on malaria and TB drug candidate discovery.

Read the full story at DEV Community — AI ↗

Timeline · 2 reports

  1. 2026-08-25 03:01 · DEV Community — AI
    Open Discovery Challenge: Benchmarking LLMs on Drug Candidate Discovery
  2. 2026-08-24 23:01 · DEV Community — Machine Learning
    VIDRAFT's Open Discovery Challenge: Claude vs. GPT-4 on Malaria & TB Drug Candidates — Early Benchmark Data

More stories

  1. Anthropic selects Accenture as first embedded evaluator to help implement Amodei's slowdown proposal — CNBC Technology
  2. OpenAI ‘ethically hacked’ with help of Anthropic’s Claude chatbot — The Guardian AI
  3. Researchers used Claude to hack OpenAI — Ars Technica AI
  4. I ran Claude code and Codex in parallel for 15 days. Here's what I found. — r/AI_Agents
  5. I built an iOS app with Claude code to break out of my usual chord habits and unlock new progressions. — r/ClaudeAI
  6. Pay $39.99 once to put ChatGPT, Claude, Gemini, and more in a single workspace for life — Mashable AI
  7. Independent Security Researchers Used Anthropic’s Claude to Break Into OpenAI — r/singularity
  8. This Ford exec put her family's Claude assistant on a PIP. ChatGPT has taken over. — Business Insider AI

Get the daily brief of stories like this at 6:30 every morning →